• Product nameAnti-Eg5 antibody
    See all Eg5 primary antibodies
  • Description
    Rabbit polyclonal to Eg5
  • Specificityab61199 detects endogenous levels of total Eg5 protein.
  • Tested applicationsSuitable for: IHC-P, WB, ICC/IF, ELISAmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse
  • Immunogen

    Synthetic non-phosphopeptide derived from human Eg5 around the phosphorylation site of threonine 927.

  • Positive control
    • Human lung carcinoma tissue, COLO205 cell extracts and HeLa cells.



Our Abpromise guarantee covers the use of ab61199 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/50 - 1/100.
WB 1/500 - 1/1000. Detects a band of approximately 120 kDa (predicted molecular weight: 120 kDa).
ICC/IF 1/500 - 1/1000.
ELISA 1/5000.


  • FunctionMotor protein required for establishing a bipolar spindle. Blocking of KIF11 prevents centrosome migration and arrest cells in mitosis with monoastral microtubule arrays.
  • Involvement in diseaseDefects in KIF11 are the cause of microcephaly with or without chorioretinopathy, lymphedema, or mental retardation (MCLMR) [MIM:152950]. An autosomal dominant disorder that involves an overlapping but variable spectrum of central nervous system and ocular developmental anomalies. Microcephaly ranges from mild to severe and is often associated with mild to moderate developmental delay and a characteristic facial phenotype with upslanting palpebral fissures, broad nose with rounded tip, long philtrum with thin upper lip, prominent chin, and prominent ears. Chorioretinopathy is the most common eye abnormality, but retinal folds, microphthalmia, and myopic and hypermetropic astigmatism have also been reported, and some individuals have no overt ocular phenotype. Congenital lymphedema, when present, is typically confined to the dorsa of the feet, and lymphoscintigraphy reveals the absence of radioactive isotope uptake from the webspaces between the toes.
  • Sequence similaritiesBelongs to the kinesin-like protein family. BimC subfamily.
    Contains 1 kinesin-motor domain.
  • Post-translational
    Phosphorylated exclusively on serine during S phase, but on both serine and Thr-926 during mitosis, so controlling the association of KIF11 with the spindle apparatus (probably during early prophase). Phosphorylated upon DNA damage, probably by ATM or ATR.
    A subset of this protein primarily localized at the spindle pole is phosphorylated by NEK6 during mitosis; phosphorylation is required for mitotic function.
  • Cellular localizationCytoplasm. Cytoplasm > cytoskeleton > spindle pole.
  • Information by UniProt
  • Database links
  • Alternative names
    • EG5 antibody
    • HKSP antibody
    • KIF11 antibody
    • KIF11_HUMAN antibody
    • Kinesin family member 11 antibody
    • Kinesin like protein 1 antibody
    • Kinesin-like protein 1 antibody
    • Kinesin-like protein KIF11 antibody
    • Kinesin-like spindle protein HKSP antibody
    • Kinesin-related motor protein Eg5 antibody
    • KNSL1 antibody
    • MCLMR antibody
    • Thyroid receptor-interacting protein 5 antibody
    • TR-interacting protein 5 antibody
    • TRIP-5 antibody
    • TRIP5 antibody
    see all

Anti-Eg5 antibody images

  • ab61199 at 1/50 dilution staining Eg5 in human lung carcinoma by Immunohistochemistry, Paraffin-embedded tissue, in the absence (left) or presence (right) of the immunising peptide.
  • ab61199 at 1/500 dilution staining Eg5 in HeLa cells, by Immunofluorescence, in the absence (left) or presence (right) of the immunising peptide.
  • All lanes : Anti-Eg5 antibody (ab61199) at 1/500 dilution

    Lane 1 : COLO205 cell extracts
    Lane 2 : COLO205 cell extracts with immunising peptide

    Predicted band size : 120 kDa
    Observed band size : 120 kDa

References for Anti-Eg5 antibody (ab61199)

This product has been referenced in:
  • Sahab ZJ  et al. Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the a-tubulin tyrosination cycle. Cancer Res 71:1219-28 (2011). WB ; Human . Read more (PubMed: 21303978) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab61199.
Please use the links above to contact us or submit feedback about this product.